Regulation of endothelial monocyte-activating polypeptide II release by apoptosis

Endothelial monocyte-activating polypeptide II (EMAP II) is a proinflammatory cytokine and a chemoattractant for monocytes. We show here that, in the mouse embryo, EMAP II mRNA was most abundant at sites of tissue remodeling where many apoptotic cells could be detected by terminal deoxynucleotidyltransferase-mediated dUTP end labeling. Removal of dead cells is known to require macrophages, and these were found to colocalize with areas of EMAP II mRNA expression and programmed cell death. In cultured cells, post-translational processing of pro-EMAP II protein to the mature released EMAP II form (23 kDa) occurred coincidentally with apoptosis. Cleavage of pro-EMAP II could be abrogated in cultured cells by using a peptide-based inhibitor, which competes with the ASTD cleavage site of pro-EMAP II. Our results suggest that the coordinate program of cell death includes activation of a caspase-like activity that initiates the processing of a cytokine responsible for macrophage attraction to the sites of apoptosis.

Six-month angiographic follow-up of the PAS-Port II clinical trial

BACKGROUND: The PAS-Port device (Cardica, Redwood City, CA) allows the rapid deployment of a clampless proximal anastomosis between a vein graft and the aorta. METHODS: Fifty-four patients awaiting elective coronary artery bypass graft surgery were enrolled. Outcome variables were intraoperative device performance, early and 6- month angiographic graft patency, and 12-month clinical follow-up. RESULTS: Sixty-three PAS-Port devices were deployed in 54 patients. Two deployments were unsuccessful. There were no reoperations for bleeding. Two patients died of causes unrelated to the device. Patency evaluation at discharge was performed by angiogram on 49 implants and computed tomography in 2 implants (86% follow-up). At discharge, all evaluated grafts were patent (100%) and rated Fitzgibbon A. At 6-month follow-up, there was no additional mortality; 47 implants (88% follow-up) were evaluated by angiography (Fitzgibbon O [n = 1], Fitzgibbon B [n = 1], and Fitzgibbon A [n = 45]) and 5 by computed tomography. All grafts but 1 were patent (98.1%). At 12 months, 2 additional patients died of causes unrelated to the PAS-Port implant. Forty-six of 50 alive patients (95.8%) were followed up without any reports of device-related major adverse cardiac events. CONCLUSIONS: Discharge (100%) and 6-month patency (98%) are excellent; patency and 12 months' clinical follow-up compares favorably with data from historical hand-sewn controls. The PAS-Port system safely allows the clampless creation of a proximal anastomosis.

The “Out of Africa Tribe” (II): Paleolithic warriors with big canoes and protective weapons

It is generally difficult to establish a timeline for the appearance of different technologies and tools during human cultural evolution. Here I use stochastic character mapping of discrete traits using human mtDNA phylogenies rooted to the Reconstructed Sapiens Reference Sequence (RSRS) as a model to address this question. The analysis reveals that the ancestral state of Homo sapiens was hunting, using material innovations that included bows and arrows, stone axes and spears. However, around 80,000 y before present, a transition occurred, from this ancestral hunting tradition, toward the invention of protective weapons such as shields, the appearance of ritual fighting as a socially accepted behavior and the construction of war canoes for the fast transport of large numbers of warriors. This model suggests a major cultural change, during the Palaeolithic, from hunters to warriors. Moreover, in the light of the recent Out of Africa Theory, it suggests that the “Out of Africa Tribe” was a tribe of warriors that had developed protective weapons such as shields and used big war canoes to travel the sea coast and big rivers in raiding expeditions.

News from an Old Excavation: Two Hitherto Unnoticed Measure Capacity Signs on an Egyptian Stone Vessel of the Middle Kingdom from Royal Tomb II at Byblos

Excavated by French Egyptologist P. Montet in the 1920s, Royal Tomb II at Byblos (Bronze Age Gubla) yielded a significant number of Egyptian objects of the Middle Kingdom. Among these finds is a stone vessel with lid that carries the cartouche of a king named Amenemhat, often believed to be Amenemhat IV of the late Middle Kingdom. Hitherto unnoticed by the scholarly community, however, are two Egyptian measure capacity signs on the stone vessel itself. Since measure capacity signs on stone vessels dating to the Middle Kingdom are only rarely attested even in Egypt, the signs on the stone vessel from Royal Tomb II at Byblos therefore contribute considerably to our understanding of the use and application of such signs. The article deals with the examination of these signs and tries to correlate them with the actual capacity of the vessel.

Galilee Blooming: First Palynological and Archaeological Data from an Early Byzantine Cistern at Horvat Kur

Preliminary archaeological and palynological results are presented from an early Byzantine cistern of the village Horvat Kur in eastern Lower Galilee/Israel. The rural site was settled from the Hellenistic until the Early Arab period, its synagogue was constructed shortly after 425 AD and renovated sometimes during the 2nd half of the 6th century AD. It was abandoned probably as a consequence of the earthquake of 749 AD. The intact and properly sealed cistern contained complete or fully restorable pottery. Two cooking pots from the early 5th century AD comprised sediments which was sampled for palynological purposes. Both samples, as well as a sample from the soil beneath one of the pots and a modern surface sample from the site, revealed well preserved palynomorphs in comparably high concentration showing a great potential of the cistern as a pollen archive. The pollen content points to an open, grassy semiarid landscape with an apparent scarcity of cultivars and trees in the vicinity of the site and an abundance of herbs, especially Asteraceae, which are still commonly found in modern regional vegetation.

The Kinneret Regional Project Excavations of a Byzantine Synagogue at Horvat Kur, Galilee, 2010-2013: A Preliminary Report

The article presents the preliminary results from four seasons of excavations at Horvat Kur in the Galilee. The excavations conducted by the Kinneret Regional Project have exposed the remains of a broad-house synagogue from the Byzantine period. The most important finds include an elevated platform (i. e., a bemah) that supported a chest holding Torah scrolls, an ornamented limestone seat that was probably used by the leader of the congregation, and a basalt stone table that features geometric figures on three sides and figurative representations on one side. The Horvat Kur synagogue represents a valuable example of the diversity of Galilean synagogues that were built or renovated between the 5th and the 7th centuries C.E.

Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II.

AIMS A non-invasive gene-expression profiling (GEP) test for rejection surveillance of heart transplant recipients originated in the USA. A European-based study, Cardiac Allograft Rejection Gene Expression Observational II Study (CARGO II), was conducted to further clinically validate the GEP test performance. METHODS AND RESULTS Blood samples for GEP testing (AlloMap(®), CareDx, Brisbane, CA, USA) were collected during post-transplant surveillance. The reference standard for rejection status was based on histopathology grading of tissue from endomyocardial biopsy. The area under the receiver operating characteristic curve (AUC-ROC), negative (NPVs), and positive predictive values (PPVs) for the GEP scores (range 0-39) were computed. Considering the GEP score of 34 as a cut-off (>6 months post-transplantation), 95.5% (381/399) of GEP tests were true negatives, 4.5% (18/399) were false negatives, 10.2% (6/59) were true positives, and 89.8% (53/59) were false positives. Based on 938 paired biopsies, the GEP test score AUC-ROC for distinguishing ≥3A rejection was 0.70 and 0.69 for ≥2-6 and >6 months post-transplantation, respectively. Depending on the chosen threshold score, the NPV and PPV range from 98.1 to 100% and 2.0 to 4.7%, respectively. CONCLUSION For ≥2-6 and >6 months post-transplantation, CARGO II GEP score performance (AUC-ROC = 0.70 and 0.69) is similar to the CARGO study results (AUC-ROC = 0.71 and 0.67). The low prevalence of ACR contributes to the high NPV and limited PPV of GEP testing. The choice of threshold score for practical use of GEP testing should consider overall clinical assessment of the patient's baseline risk for rejection.

Na 1 Nachlass Max Horkheimer, 81 - Korrespondenzen u.a. mit Julius Marx und Alexander Mitscherlich (p. II 11, 53-295)

22 Briefe zwischen Robert M. MacIver und Max Horkheimer, 1941-1947; 4 Briefe und Beilage zwischen Julius B. Maller vom Amercian Jewish Committee und Max Horkheimer, 1945-1946; 3 Briefe zwischen Eric Mann und Max Horkheimer, 1947; 13 Briefe und Beilagen zwischen Ludwig Marcuse und Max Horkheimer, 1941-1948 sowie 1 Manuskript von Ludwig Marcuse: War Guilt and Peace Aims, dazu von Max Horkheimer Gutachten und Entwürfe; 8 Briefe zwischen Siegfried Marck und Max Horkheimer, 1945-1950; 7 Briefe zwischen Claire Marck vom American Jewish Committee und Max Horkheimer, 1945-1946; 4 Briefe zwischen Alfred von Martin und Max Horkheimer, 1948-1949; 2 Briefe und Beilage zwischen Hugo Marx und Max Horkheimer, 1945; 44 Briefe und Beilage zwische Julius Marx und Max Horkheimer, 1945-1949; 2 Briefe und Beilage zwischen Heinrich Meng und Max Horkheimer, 10.07.1942, 29.10.1942; 5 Briefe zwischen Karl Menges und Max Horkheimer, 1943-1944; 8 Briefe und Beilage Karl A. Menninger, William C. Menninger und Max Horkheimer, 1941-1949; 23 und Beilage Joseph Messinger und Max Horkheimer, 1945-1949; 2 Briefe zwischen Robert K. Merton und Max Horkheimer, 1949; 1 Brief von Fritz Merz an Max Horkheimer, 1949; 9 Briefe zwischen Fred Mielke und Max Horkheimer, 1948-1950 siehe auch Alexander Mitscherlich; 1 Brief von Max Horkheimer bzw. Theodor W. Adorno an George Mintzer, ca. 1944; 5 Briefe zwischen Walter G. Muelder und Max Horkheimer, 1942-1943; 21 Briefe und Beilage zwischen Dorothy Mulgrave und Max Horkheimer, 1941-1948; 2 Briefe zwischen Arthur E. Murphy und Max Horkheimer, 1947;